EZZ Life Science: Diversification, Innovation and Growth Drive Fiscal Year 2022 Successfully - World News Report

EZZ Life Science: Diversification, Innovation and Growth Drive Fiscal Year 2022 Successfully – World News Report

Glenn Cross, Chairman, EZZ LIfe Science

EZZ Bone Health Supplements

EZZ hair products

Glenn Cross, Chairman of EZZ Life Science (ASX:EZZ), praised his company’s unwavering discipline, high work ethic and diversification during the pandemic.

The continued success of EZZ Life Science as a business has resulted in an 18 percent increase in our cash position and has set the business up for strong growth in 2023 and beyond.”

— EZZ Life Science, Chairman, Glenn Cross

SYDNEY, NSW, AUSTRALIA, September 20, 2022 /EINPresswire.com/ — Leading Australian company in the field of genomics in the life sciences, EZZ Life Scienceposted extremely pleasing financial year 2022 results, ensuring strong global growth in 2023 and beyond.

“Despite significant market disruption and uncertainty, EZZ Life Science’s diversified distribution channels have resulted in a significant increase in revenue and a successful end to fiscal 2022. In the second half of the fiscal year, the company demonstrated a rapid recovery in earnings, resulting in total revenue for the fiscal year of $15,022,026. This is an excellent result that strengthens our position for further growth and expansion,” said EZZ Life Science Chairman Glenn Cross.

Strong sales growth

“The second half of fiscal year 2022 was characterized by strong growth in revenue from sales of EZZ Life Science products. While the company’s FY 2022 revenue declined due to the effects of the pandemic, operational efficiency improved and the foundation was laid for strong growth going forward,” Cross said.

“Together with the rest of the world, we are overcoming COVID and moving forward. Our solid sales figures are proof of this: the lockdown is over, the economy is recovering and our customers’ spending is on the rise. In the second half of fiscal year 2022, we saw a 24 percent increase in sales revenue compared to the previous corresponding period. In addition, our growth in the second half corresponds to a 96 percent increase in sales revenue compared to the first half of fiscal 2022.

“The continued success of EZZ Life Science as a business has resulted in an 18 percent increase in our cash position, bringing our cash position to $10.5 million as of June 30, 2022. The expansion of our worldwide distribution network during the financial year is producing good results.

“While many businesses in the sector have panicked, rationalized and reduced their operations and marketing spending, we have focused on increasing investment in our business to prepare the company for strong post-COVID growth, and the work is clearly delivering great results.”

Outstanding Success in Cross-Border Online Store Diversification

“In June 2022, we launched our cross-border e-commerce store on Douyin, the mainland China version of TikTok, as an alternative direct channel for Tmall Global customers. Revenue growth from this new channel exceeded our expectations in the first month of operation. With its outstanding success, we have made Douyin another key e-commerce platform along with Tmall Global to reduce the company’s concentration on a single e-commerce platform in the China market,” Cross said.

“Our strategy for adopting and using social media platforms with a growing number of users, sophisticated targeting options, and sophisticated sales tools enhances our ability to reach more customers with greater accuracy and efficiency.

“On the other hand, revenue generated through Tmall Global as a key distribution channel fell in the first half of FY 2022, however it gradually declined in the second half of FY 2022 due to our rapidly deployed digital strategy. platform diversification.

Expanded product range

“We have also expanded our product portfolio with the addition of seven new products and the addition of a new category, hair products,” Cross said.

“Three of these new products generated 16% of total revenue in fiscal 2022. Four new EZZ hair care products launched at the end of the financial year and are also growing in sales volume.

“Our EZZ Growth Capsule L-Lysine was introduced in July 2021 and represents another successful high-margin product that generated 27 percent of revenue from EZZ-branded products.

“In fact, our EZZ L-Lysine Growth Capsule is now the category leader in children’s supplements at Tmall Global. It also leads in repeat purchases and positive reviews. Considering the size of Tmall Global and the large user base of around 600 million monthly users, this is a great result for our business and the EZZ brand.

“We have invested heavily in research and development on our children’s bone health supplement. EZZ L-Lysine Growth Capsule is a premium formula with over 380 mg of the amino acid lysine per capsule to promote healthy growth and development in children and teens.

“Our special blend contains not only lysine, but also calcium, vitamin D3, zinc, magnesium and other ingredients that support bone health, muscle function, immune system health and cognitive development. This is a powerful capsule that is considered the market leader in its category.”

Successful recovery paves the way forward

“Undoubtedly, restrictions due to the pandemic have negatively affected businesses around the world, and EZZ Life Science is not immune from these consequences. As people’s lives begin to return to some sense of normalcy, we expect further recovery and growth,” Cross said.

“Our clear strategy, which includes continuous product development and expansion of our distribution networks and points of sale, is producing excellent results and we look forward to continuing our strong and reliable path forward in this regard.

“As a relatively new but rapidly growing business, our strategic goal is to maintain our continued commitment to growing brand awareness and trust in our science-based and consumer-focused products. Most of our products are listed on the Australian Therapeutic Goods Registry and supported by a range of research projects, including university trials.

“The world is at the epicenter of a health and wellness revolution driven by consumers who want more control over how they manage their wellbeing. Crucial to this is the need for trust and transparency along the path to purchase. At the heart of our operations is a clear goal to ensure that our brand appears in as many physical and digital touchpoints as possible, and the strength and validity of our science-based approach is inherent in everything we do and the market’s interaction with our brand and products. . This is the kind of brand trust that consumers want and need in this turbulent environment.”

Tess Sanders Lazarus, Chief Publicist
Invigorate PR – global PR for entrepreneurs and businesses
Ipublicrelations.net
Visit us on social networks:
facebook
LinkedIn

.

Tags: , ,
Previous Post
BitcoinZ provides Connect-Z, a new type of decentralized gateway connecting the BTCZ ecosystem with Binance Smart Chain
Blog

BitcoinZ provides Connect-Z, a new type of decentralized gateway connecting the BTCZ ecosystem with Binance Smart Chain

Next Post
German rosette: Protección de datos de jugadores es fundamental point el deporte moderno - World News Report
Blog

German rosette: Protección de datos de jugadores es fundamental point el deporte moderno – World News Report

Leave a Reply

Your email address will not be published. Required fields are marked *